Finding clinical endpoints in patients with ARID1B-related intellectual disability
- Conditions
- ARID1B
- Registration Number
- NL-OMON25725
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
o
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 24
Inclusion Criteria
ARID1B group
•Informed consent provided by both parents or the legal guardian prior to any study-mandated procedure.
Exclusion Criteria
•Clear indication of not wanting to participate during the study
•Use of benzodiazepines or any other medication with the potential to influence study related endpoints in the investigator’s opinion.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method